Clinical trials: Patients With Obstructive Jaundice
Systemic Inflammatory Response Syndrome, Jaundice, Obstructive
Cholinergic Anti-inflammatory Pathway in Prevention & Treatment of the SIRS in Patients With Jaundice After Operation.
RATIONALE:Anticholinesterase drugs and cholinergic M receptor antagonist are applied to patients who have obstructive jaundice after operation.
- Trial name
- NCT02279147
- Testing
- neostigmine methylsulfate，raceanisodamine hydrochloride
- Where
- China
- Volunteers
- 100 people
- Sponsor
- Wanqing Gu
Pancreatic Cancer
SEMS Placement Before Surgery in Unblocking Bile Duct in Patients With Periampullary Pancreatic Cancer With Severe Obstructive Jaundice
This trial studies the side effects of self expanding metal stent (SEMS) placement before surgery in unblocking the bile duct in patients with periampullary pancreatic cancer with severe obstructive jaundice.
- Trial name
- NCT03820544
- Testing
- Endoscopic Retrograde Cholangiopancreatography, Standard of care
- Where
- United States
- Volunteers
- 4 people
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Obstructive Jaundice
Pre-treatment With Methylene Blue Prevent Peri-operative Reduced Systemic Vascular Resistance
To explore the effects of pre-treatment with methylene blue on reduced perioperative vascular resistance in patients with obstructive jaundice.
- Trial name
- NCT03406676
- Testing
- Methylene Blue
- Where
- 2 sites in China
- Volunteers
- 70 people
- Sponsor
- Southwest Hospital, China